Literature DB >> 1517155

Isolation, characterization and biological activities of concanamycins as inhibitors of lysosomal acidification.

J T Woo1, C Shinohara, K Sakai, K Hasumi, A Endo.   

Abstract

Four new analogues of concanamycin family, designated concanamycins D, E, F G, were isolated from the mycelium of Streptomyces sp. A1509 by solvent extraction, silica gel column chromatography and HPLC. Structures of these compounds were identified by the combination of spectroscopic analyses. All of these compounds were structurally related to concanamycins A, B and C, which had been isolated previously, and inhibited the acidification of rat liver lysosomes at 10(-11)-10(-9) M concentration. The structure-activity study showed that the 18-membered macrolide ring and the 6-membered hemiketal ring portions of the molecules of concanamycin family are responsible for potent inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517155     DOI: 10.7164/antibiotics.45.1108

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  15 in total

1.  Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.

Authors:  Ryan S Funk; Jeffrey P Krise
Journal:  Mol Pharm       Date:  2012-04-06       Impact factor: 4.939

2.  Inactivation and proteolytic degradation of perforin within lytic granules upon neutralization of acidic pH.

Authors:  T Kataoka; K Togashi; H Takayama; K Takaku; K Nagai
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

3.  Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.

Authors:  Zahia Ouar; Marcelle Bens; Caroline Vignes; Marc Paulais; Claudine Pringel; Jocelyne Fleury; Francçoise Cluzeaud; Roger Lacave; Alain Vandewalle
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

4.  Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones.

Authors:  S J Gagnon; F A Ennis; A L Rothman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Control of Amino Acid Homeostasis by a Ubiquitin Ligase-Coactivator Protein Complex.

Authors:  Damian Guerra; Sonia M Chapiro; Réjane Pratelli; Shi Yu; Weitao Jia; Julie Leary; Guillaume Pilot; Judy Callis
Journal:  J Biol Chem       Date:  2017-01-18       Impact factor: 5.157

6.  FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation.

Authors:  T Kataoka; A Yamada; M Bando; T Honma; K Mizoue; K Nagai
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

7.  Concanamycin A, a vacuolar type H(+)-ATPase inhibitor, induces cell death in activated CD8(+) CTL.

Authors:  K Togashi; T Kataoka; K Nagai
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

8.  The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4.

Authors:  Mandana Mansouri; Eric Bartee; Kristine Gouveia; Bianca T Hovey Nerenberg; John Barrett; Laurel Thomas; Gary Thomas; Grant McFadden; Klaus Früh
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  Regulation of vesicular pH in liver macrophages and parenchymal cells by ammonia and anisotonicity as assessed by fluorescein isothiocyanate-dextran fluorescence.

Authors:  R Schreiber; F Zhang; D Häussinger
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

10.  Quantitative and time-resolved monitoring of organelle and protein delivery to the lysosome with a tandem fluorescent Halo-GFP reporter.

Authors:  M Rudinskiy; T J Bergmann; M Molinari
Journal:  Mol Biol Cell       Date:  2022-02-02       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.